Ipca Laboratories Ltd. benchmarking: Performance to industry peers

Financial

	Ipca Laboratories	Glaxosmithkline Phar	Ajanta Pharma
Operational Metrics
Pharmaceuticals
Number of ANDA's Filed in USA	44.0 .	n/a	75.0 .
Number of ANDA's Approved By USFDA	31.0 .	n/a	56.0 .
Domestic Sales Growth - YoY	11.1 %	7.5 %	7.5 %
US DMF Filings	55.0 .	n/a	n/a
R&D as a % of Total Sales	3.12 %	0.07 %	5.0 %
Financials
5 yr Average ROE	13.55 %	45.03 %	21.93 %
5yr average Equity Multiplier	1.52	1.87	1.33
5yr Average Asset Turnover Ratio	0.76	0.92	0.86
5yr Avg Net Profit Margin	11.88 %	27.88 %	19.12 %
Price to Book	5.09	17.62	8.77
P/E	35.97	38.57	37.6
5yr Avg Cash Conversion Cycle	54.3 Days	-107.65 Days	-104.16 Days
Inventory Days	102.83 Days	47.69 Days	45.5 Days
Days Receivable	72.68 Days	24.45 Days	49.07 Days
Days Payable	111.38 Days	155.09 Days	180.12 Days
5yr Average Interest Coverage Ratio	50.79	556.84	103.83
5yr Avg ROCE	17.31 %	48.35 %	28.04 %
5yr Avg Operating Profit Margin	19.8 %	27.99 %	25.85 %
5 yr average Debt to Equity	0.17	0.0	0.01
5yr CAGR Net Profit	-8.34 %	-9.37 %	8.18 %
5yr Average Return on Assets	9.41 %	24.4 %	16.5 %
Shareholdings
Promoter Holding	44.72 %	75.0 %	66.25 %
Share Pledged by Promoters	0.0	0.0	17.94 %
Change in Promoter Holding (3 Yrs)	-1.57 %	0.0	0.14 %
Change in Mutual Fund Holding (3 Yrs)	1.3 %	0.77 %	1.45 %

Business

	Ipca Laboratories	Glaxosmithkline Phar	Ajanta Pharma
Product Wise Break-Up	Product Wise Break-Up Branded Generics 50.39 Formulations 33.08 Active Pharmaceutical Ingredient (API) 16.53 Vaccines 0 Pharmaceuticals 0 Pharmaceutical products 0	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 0 Pharmaceutical 76.0 Branded Generics 0 Formulations 0 Vaccines 24.0 Pharmaceutical products 0	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 0 Pharmaceuticals 0 Branded Generics 0 Formulations 0 Vaccines 0 Pharmaceutical 100.0
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Pain 53.0 Cardiac Science 17.0 Dermatology 6.0 Urology 5.0 Anti-bacterial 5.0 Cough and colds 4.0 Central Nervous System (CNS) 3.0 Anti Malarials 3.0 Gastro Intestinal 2.0 Neutraceuticals 1.0 0 Respiratory 0 Hormones 0 Pain/Analgesics 0 Vaccines 0 Anti-Infectives 0 Vitamins/Minerals/Nutrients 0 Others 1.0	Therapeutic Area Wise Break-Up - Domestic Cough and colds 0 Pain Management 11.96 Anti-bacterial 0 Vitamins / Minerals / Nutrients 6.47 Anti Malarials 0 Pain 0 Neutraceuticals 0 Cardiac Science 0 Urology 0 Hormones 8.91 Vaccines 12.64 0 Anti-Infective 22.25 Gastro Intestinal 0 Dermatology 30.55 Respiratory 3.95 Central Nervous System (CNS) 0 Others 3.27	Therapeutic Area Wise Break-Up - Domestic Cough and colds 0 Pain/Analgesics 0 Anti-bacterial 0 Vitamins/Minerals/Nutrients 0 Anti Malarials 0 Pain 10.0 Neutraceuticals 0 Cardiac Science 0 Urology 0 Hormones 0 Vaccines 0 0 Anti-Infectives 0 Gastro Intestinal 0 Dermatology 22.0 Respiratory 0 Central Nervous System (CNS) 0 Others 68.0
Location Wise Break-Up	Location Wise Break-Up India 44.73 USA 21.58 Europe 15.68 Africa 6.72 Asia Pacific 5.18 Australia 3.2 CIS 2.91 Rest of the World 0 Asia 0	Location Wise Break-Up Europe 0 Rest of the World 1.36 Africa 0 India 98.64 Asia Pacific 0 Asia 0 CIS 0 Australia 0 USA 0	Location Wise Break-Up Europe 0 Rest of the World 0 Africa 16.28 India 28.59 Asia Pacific 0 Asia Pacific 19.39 CIS 0 Australia 0 USA 35.74
Therapeutic Area Break-Up	Therapeutic Area Break-Up Cardiovascular & Anti Diabetics 25.0 Anti Malarials 24.0 NSAID 21.0 Neuro 7.0 GI 6.0 Cough 2.0 Nutraceuticals 0 Urology 0 Dermatology 0 Others 15.0	-	-

Ipca Laboratories Ltd.

Ipca Laboratories Ltd.

Financial

Business

SIGN UP FOR FREE